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The finding that the secondary immune response to a haptenic determinant 
is maximized by presenting the hapten on the carrier used for primary immuni- 
zation has been termed the "carrier effect" (1-3).  Recent investigations have 
indicated that secondary stimulation by the hapten on other carriers  can be 
enhanced by immunization to the heterologous carrier or the transfer of  cells 
from an  animal immunized to the heterologous carrier  (4-6).  These findings 
have led to the postulate that in order to obtain haptenic stimulation two cells 
must  interact,  one specific  for carrier  determinants  and  one  specific  for the 
haptenic determinant. 
This report describes analyses of secondary stimulation to a hapten in vitro. 
Secondary stimulation was carried out with 2,4-dinitrophenyllysine on hemo- 
cyanin (DNP-Hy),  1 the homologous carrier,  and a variety of other carriers in 
a  wide  range  of  concentrations.  The  results  indicate  that  stimulation  was 
maximized by the use of Hy as the carrier; however, significant stimulation was 
observed with DNP on a  variety of carriers including poly-L-lysine and poly- 
D-lysine, relatively nonimmunogenic carriers  (7,  8).  In addition, antigen con- 
centrations presenting as little as 10  -13 M DNP were sufficient for stimulation 
using either homologous or heterologous carriers.  A major difference between 
the presentation of the hapten on Hy as compared to other carriers, however, 
was observed at relatively high antigen concentrations. At antigen concentra- 
tions presenting  10  -6 M DNP, DNP-Hy was stimulatory, while  on nonhomol- 
ogous carriers this DNP concentration was inhibitory. 
These  results  are  discussed  with  a  view to  elucidating  the  mechanism  of 
secondary stimulation and the role of cell-to-cell  interactions in this response. 
* This research was supported in part by U. S. Public Health Service grant AI-08778 and 
by a Public Health Service Research Career Program Award AI-33983 from the National 
Institute of Allergy and Infectious Diseases. 
i Abbreviations used in this paper: B'yG, bovine "y globulin; B-lymphocytes,  bone marrow- 
derived cells; DNP,  2,4-dinitrophenyllysine; DNP-lys-BAC, DNP-lysyl-bromacetyl  cellu- 
lose; DNP-lys, E-DNP-L-lysine;  HSA, human serum albumin; Hy, hemocyanin;  PBS, sodium 
phosphate buffer; T-lymphocytes,  thymus-dependent cells. 
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Materials and Methods 
Antigens  and  Immunoadsorbants.--Hemocyanin  (Hy)  was prepared by  Sephadex G-200 
chromatography (Pharmacia Fine Chemicals, Inc., Uppsala, Sweden) of the hemolymph of 
Limulus polyphemus. Human serum albumin  (HSA)  and bovine "/globulin  (B'yG)  were ob- 
tained from Armour Industrial Chemicals Co.,  Chicago,  Ill. Poly-D-lysine  (75,000 mo]  wt) 
and poly-L-lysine  (75,000 tool wt) were obtained from Miles-Yeda, Rehovot, Israel. Proteins 
were coupled to the 2,4-dinitrophcnyl haptenic group by reacting 1 g of 2,4-dinitrobenzene 
sulfonate (Eastman Kodak  Co.,  Rochester,  N.  Y.)  with  3  g  of protein  (9).  After  exten- 
sive dialysis against 0.02 M sodium phosphate buffer  (PBS),  pH  7.2,  and  0.15 ~  sodium 
chloride, these DNP-protein complexes were analyzed for nitrogen content by micro-Kjeldahl 
and optical density at 360 m# by a Zeiss PMQII spectrophotometer. Assuming a molar ex- 
tinction coefficient for the DNP determinant of 17,400 (10), DNP-Hy was shown to contain 
10 moles of DNP/100,000 g of Hy, DNP-HSA contained 22 moles of DNP/70,000 g of HSA, 
and  DNP-BS'G contained  21  moles of  DNP/150,000  g  of B'vG.  DNP-poly-I)-lysine and 
DNP-poly-L-lysine were prepared according to the method of Kantor et al.  (11). After ex- 
tensive dialysis,  these compounds were tested by nitrogen content and optical density. DNP- 
poly-I)-lysine  contained 22 moles of DNP/75,000  g of poly-I)-lysine  and DNP-poly-L-lysine 
contained 34 moles of DNP/75,000 g of poly-L-lysine. 
a,N[3H] acetyl-~-DNP-L-lysine  was prepared as previously described as was the immuno- 
adsorbant  DNP-lysyl-bromacetyl cellulose  (DNP-lys-BAC)  (12). e-DNP-L-lysine  (DNP- 
lys) was obtained from Yeda, Rehovot, Israel. 
Radloimmunoassay.--The  radioimmunoassay used  to  measure  antibody  concentrations 
and  the purification of the mouse anti-DNP antibody used to standardize this assay have 
been previously described (13). 30/zg of DNP-Iys-BAC was used as the immunoadsorbent 
for each analysis and  125I-rabbit  anti-mouse immunoglobulin Fab fragment  (13) was used 
to detect bound anti-DNP antibody. 0.1 ml of culture fluid was used for each antibody analy- 
sis. The radioimmunoassay for anti-Hy antibody was also carried out as previously described 
(14). 
Mouse Immunlzatlons.--BALB/c  mice 2-3 months of age were immunized by the intra- 
peritoneal injection of 0.1  mg of I)NP-Hy in complete Freund's adjuvant.  Sera antibody 
concentrations, assayed by the radioimmunoassay, showed a maximum concentration of 0.3 
mg/ml 2-4 wk after immunization. Sera anti-DNP antibody concentrations were less than 
20 ng/ml 4-8 months after immunization when the animals were used as spleen cell donors 
or were secondarily immunized in vivo. Secondary immunizations were carried out by intra- 
peritoneal injections with 50 #g of DNP-Hy in PBS. 
Cell Transfers.--Spleens  were removed and cells were separated by a  teflon pestle tissue 
homogenizer. Cells  were washed and  resuspended in Dulbecco's modified Eagle's medium 
(Grand Island Biological  Co., Grand Island, N. Y.). 30-40 million  cells in 0.3 ml doses were 
injected into a tail vein of syngenic recipients irradiated with 900 R  24 hr previously. Non- 
immunized controls were obtained by injecting 4  )<  l0  T cells obtained from spleens of non- 
immunized mice. 
Fragment Cultures.--24  hr after cell transfer spleens were removed and cut into 1-1.2  mm 
cubes. Culture conditions were similar to those previously described (14, 15). Each fragment 
was placed in 0.5  ml of Dulbecco's modified Eagle's medium supplemented with 50 #1  of 
horse serum from which gamma globulin was removed (Hyland Laboratories, Yonkers, N. Y.), 
25/zl of 10 day chick embryo extract (a gift from Dr. Jay Lash), 50 units of penicillin, and 50 
#g of streptomycin. Cultures were incubated in a moist chamber at 37°C in an atmosphere 
of 93%  02  and  7%  CO2 . Media were removed and replaced at 2-3  day intervals for the 
duration of the cultures. Antigen was added to the culture fluid  24 hr after cultures were NORMAN R.  KLINMAN  965 
initiated. Fragments were rinsed free of antigen containing culture fluid 2-4 days after anti- 
gen was added. For inhibition studies,  the inhibitor was added to the fragment cultures at 
least 1 hr before antigen was added and was removed at the time of antigen removal. 
Collected culture fluids were analyzed for anti-DNP and anti-Hy antibody content by the 
radioimmunoassay.  Results are presented as the average amount of antibody produced per 
fragment per day. Included in this average were all fragments stimulated under the stated 
conditions in at least three separate experiments.  In each experiment 4 fragments were uti- 
lized for each experimental point so that the data presented represented the results of at 
least 12 fragments for each point. In general a single experiment  consisted of 100-120 frag- 
ments obtained from four to six recipient mice which had received pooled spleen cells from 
two donor mice. 
Equilibrium Dialysis.--Equilibrium dialysis was carried out as previously described  (12, 
13). Sera and culture fluids were twice precipitated with 40% saturated ammonium  sulfate 
and dialyzed against PBS before analysis. 
RESULTS 
Fig.  1  shows  the  amount  of anfi-DNP  antibody released by fragments  at 
various times after  stimulation with  0.1 mg of DNP-Hy.  Antibody was  first 
detected at day 6-8 and reached a maximum at day 12-14. Such a  response was 
observed in at least 80%  of fragments tested. Antibody production continued 
for at least a month in these cultures. If no DNP-containing antigen was added 
to culture fluids or if cells from nonimmunized mice were used  as donor cells, 
no anti-DNP antibody production was observed. Similar results were  obtained 
when culture fluids from these fragments were analyzed for anti-Hy production. 
At least 80%  of  the fragments  produced  anti-Hy antibody with  an  average 
maximum release of 70 ng/day at day 14. 
Stimulation  by DNP-Hy  was  partially inhibited  when  carried  out  in  the 
presence of relatively high concentrations of DNP-lysine or Hy. Table I  sum- 
marizes  the  data  obtained  from  cultures  stimulated  in  the  presence  of  free 
hapten  or carrier. These  results are consistent with those previously reported 
by several investigators (16-17).  2 Control studies indicated that  10-SM DNP- 
lysine did not  reduce the amount  of anti-Hy antibody produced  by cultures 
stimulated with DNP-Hy. 
Fig. 2 shows the effect on stimulation of variations in the carrier used in the 
stimulatory complex and the concentration of the various antigens used. Fig. 3 
presents  the same data calculated on  the basis of DNP  molarity. Maximum 
stimulation  was  obtained  with  0.1 tzg/ml  of  DNP-Hy;  however,  significant 
stimulation was obtained with concentrations as high as 100 #g/ml and as low 
as 10  -6 #g/ml.  Significant stimulation was also observed with DNP-HSA  and 
DNP-B~G at concentrations as high as 1/~g/ml and as low as 10  -G b*g/ml. DNP- 
poly-L-lysine stimulated at concentrations as high as 0.03/~g/ml and as low as 
2 Feldman, M. et al. 1970. Presented  at the Third Sigrid Juselius Foundation Symposium. 
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3 X  10  -7/zg/rnl while DNP-poly-D-lysine  was stimulatory at concentrations as 
high as 2 X  10  .4/zg/ml and as low as 2  X  10  -7/~g/rnl. With all antigens DNP 
concentrations as low as 10.13 M were stimulatory. DNP on carriers other than 
0  2  4  6  8  I0  12  14  16  18  20  22  24 
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FIG. l. The release of anti-DNP antibody by spleen fragment cultures with  time after 
in vitro  stimulation with 0.1  #g/ml of DNP-Hy. Points represent  arithmetic  mean  (with 
standard  deviation) of data averaged from radioimmunoassays of culture  fluids from frag- 
ment cultures from 10 separate experiments. 
TABLE  I 
Inhibition  of DNP-Hy Stimulation by DNP-Lysine and Hy 
Antigen  Inhibitor  Maximum amount of 
antibody released  per 
DNP-Hy  DNP-lys  Hy  culture per day (and sD) 
(~g/ml)  (M)  (~g/ml)  (rag) 
0.1  --  --  47  ±4 
1.0  --  --  42  q-  5 
10.0  --  --  24  ±  4 
0.1  10  -8  --  26  4-  6 
0.1  10  -5  --  12  ±  3 
1.0  10  -5  --  18  4- 4 
0.1  --  100  14  4-  4 
1.o  --  100  8  4-  3 
10.0  --  100  4  4-  2 
Hy at concentrations of 10  .6 ~t and greater was not stimulatory. Table II shows 
the inhibitory effects of DNP on carriers other than Hy.  It can be seen that 
the  stimulatory effects  of  0.1 ~g/ml of  DNP-Hy could be inhibited by high 
concentrations of  DNP  on nonhomologous carriers.  In all instances anti-Hy NORMAN  R.  KLINMAN  967 
antibody  production  by  these  fragments  was  essentially  unaffected  by  the 
presence of such concentrations of these antigens. 
Equilibrium  dialysis studies  showed that  the  binding  of  alN [3H]-acetyl-e- 
DNP-IAysine at 7°C by antibody present in the serum of secondarily stimulated 
BALB/c  mice,  and  that  in  the  culture  fluid  of  fragments  stimulated  with 
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Fro. 2.  The dependence of secondary in vitro stimulation on antigen concentration and 
hapten-carrier complex.  Antigen concentration  is  presented  as  micrograms per  milliliter. 
Each point represents the arithmetic mean  (with standard deviation) of antibody released 
per fragmen  t  per day by at least 12 fragment cultures stimulated identically. Closed circles 
(I)  represent stimulation with various concentration of DNP-Hy,  open circles  (O)  repre- 
sent  stimulation with DNP-BTG,  crosses  (X)  represent stimulation with DNP-HSA,  tri- 
angles (ZX) represent stimulation with DNP-poly-D-lysine, and inverted triangles (V) repre- 
sent stimulation with DNP-poly-L-lysine. 
1 ~g/ml or 10  -3 ~g/ml of DNP-Hy, were essentially the same. The Ka of the 
serum antibody was 2.4 X  10  7 ~¢-i while that of antibody from pooled media of 
fragments stimulated with  1 #g of DNP-Hy was 2.1  X  10 7 M  -1 and antibody 
produced by fragments stimulated with 10-  3/zg/ml of DNP-Hy was 2.6 X  10  7 
M--I 
DISCUSSION 
This report describes an analysis of antigenic stimulation of the secondary 
immune  response to DNP  in  vitro.  The results  indicate  that:  (a)  maximum 
stimulation  was  obtained  with  DNP  complexed to Hy,  the  carrier used  for 
primary immunization,  (b)  stimulation was obtained with the hapten on non- 968  ANTIGEN  CONCENTRATION  AND  THE  CARRIER  EFFECT 
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FIG. 3.  The dependence  of secondary in vitro stimulation on antigen  concentration and 
hapten-carrier  complex.  Antigen concentration  is presented  as molar concentration  of  the 
DNP determinant. Each point represents the arithmetic mean of antibody released per frag- 
ment per day by at least  12  fragments. The data presented in this figure and the standard 
deviation of the calculated  points are the same as in Fig.  2. As in Fig. 2,  closed circles  (e) 
represent stimulation with DNP-Hy, open circles (O) represent stimulation with DNP-B'yG, 
crosses (X)  represent stimulation with DNP-HSA, triangles (A) represent stimulation with 
DNP-poly-D-Iysine,  and  inverted  triangles  (V)  represent  stimulation  with  DNP-poly-L- 
lysine. 
TABLE  II 
The Inhibition of the In Vitro Response to DNP-Hy by DNP on  Heterologous Carriers 
Antigen  Maximum amount of 
antibody released 
per culture per  DNP-Hy  DNP-HSA  DNP-B~G  DNP-P-L-lys  DNP-P-D-lys  day (and sD) 
(zg/ml)  (mg) 
.....  <0.5 
0.1  ....  47  ±4 
0.1  11  --  --  --  6  ±2 
0.1  110  --  --  <0.5 
0.1  --  9  --  --  3~2 
0.1  --  90  --  --  <0.5 
0.1  --  --  0.3  --  11  4-  5 
0.1  --  --  3  --  <0.5 
0.1  --  --  --  0.2  24-  1 
0.1  --  --  --  2  <0.5 NORMAN  R.  KLINMAN  969 
homologous  carriers  including  DNP-poly-I)-lysine,  a  poor  immunogen,  (c) 
stimulation was obtained with the hapten on homologous and nonhomologous 
carriers at  antigen concentrations as  low as  10  -8 #g/ml  (10-last DNP),  and 
(d)  at  an  antigen  concentration  of  10/~g/ml  (10-6M  DNP)  and  greater, 
DNP-Hy was stimulatory while DNP  on nonhomologous carriers specifically 
inhibited the response to DNP. 
Several investigators have reported the in vivo stimulation of anti-hapten 
antibody by hapten  on nonhomologous carriers (18,  19).  However, other in- 
vestigators have found that hapten on the homologous carrier is a much better 
immunogen and have implied that specific recognition of carrier determinants 
enhances the affinity of hapten recognition (20). 
The demonstration, in this report, that stimulation of a secondary response 
was obtained at equally low concentrations of the hapten on homologous and 
nonhomologous carriers indicates that the affinity of the hapten cell interaction 
was independent of the carrier molecule. The affinity of the antibody produced 
after stimulation  with  DNP-Hy  in  a  concentration  of  10  -~/~g/ml  (10-1° M 
DNP)  was  2.6  X  107 ~r  -1.  Since the hapten was presented in  a  multivalent 
form,  it  is  possible  that  the  affinity of cell-bound antibody for hapten  was 
greatly enhanced by multivalent binding (21-24). Thus cell-bound antibody of 
an affinity of 2.6 X  107 M  -1 for a monovalent hapten could bind a multivalent 
antigen with  an affinity more than two logarithms higher.  From the  results 
presented here such multivalent interactions appear more likely to explain the 
stimulatory capacity of low antigen concentrations than would specific inter- 
actions with carrier determinants. 
On the other hand, specific recognition of the homologous carrier appeared 
highly significant at higher antigen concentrations. DNP  on nonhomologous 
carriers  specifically inhibited  the  response to DNP  at  concentrations where 
DNP-Hy was stimulatory. Thus while a stimulatory interaction of the haptenic 
determinant in a polyvalent form and an immunocompetent cell may be pos- 
sible, the general mechanism of antigenic stimulation is probably more complex. 
Mitchison and his  co-workers consider the carrier  effect as  a  function  of 
thymus-dependent cells (T-lymphocytes) which recognize carrier determinants. 
Such cells presumably bind the hapten-carrier complex and present the hapten 
in a  concentrated form to bone marrow-derived cells (B-lymphocytes) which 
recognize the hapten and upon  stimulation produce antibody against  it  (3). 
Two cells which recognize determinants on the same antigen molecule could 
possibly form a highly stable complex if both shared in the simultaneous binding 
of numerous antigen molecules (21-24). Cell-to-cell interactions could thus play 
a  role in antigenic stimulation if such stable complexes between antigen and 
cells were necessary. Such interactions would be minimized at very low antigen 
concentrations where too few antigen molecules would be available for stable 
cross-linking and at very high antigen concentrations where cross-linking would 970  ANTIGEN  CONCENTRATION  AND  TIt-E  CARRIER  EFFECT 
be minimized by blockage of antigen binding sites.  Stimulation of anti-DNP 
antibody production, in vitro, by low concentrations of hapten on homologous 
and nonhomologous carriers could result from interactions of two cells recog- 
nizing DNP. Since this determinant is polyvalent it may be capable of simul- 
taneous interaction with cell-bound antibody of more than one cell. Because of 
its polyvalence, its interaction with cell-bound antibody may be of relatively 
high affinity. Thus saturation of DNP receptor sites may be reached at relatively 
low antigen  concentrations.  Receptor sites  recognizing carrier determinants, 
however, may still be available for cross-linkage at higher antigen concentra- 
tions. Thus the recognition of Hy would enhance stimulation of anti-DNP cells 
at high antigen concentrations. This is consistent  with the finding that high 
concentrations of Hy-inhibited stimulation with DNP-Hy. 
This  mechanism  for  stimulation  through  cell-to-cell interaction  does  not 
differentiate between the types of cells involved. It is possible that the inter- 
action of two B-lymphocytes could be mutually stimulatory. Such a mechanism 
has been postulated for the stimulation of "mono-focal" antibody production 
where stimulation shows enhancement by carrier recognition but can occur in 
the absence of carrier specific cells (14). On the other hand,  the presence of 
T-lymphocytes recognizing determinants on the antigen molecule could serve 
to increase the probability of productive interactions of antigen and hapten 
specific B-12clnphocytes.  This would  be consistent with the marked  enhance- 
ment  of  antigenic  stimulation  generally observed in  the  presence  of carrier 
recognition. An interesting correlate of the above hypothesis is the possibility 
that tolerance may be produced by simple antigen-cell interactions or by the 
formation of unstable complexes between two cells cross-linked by only a few 
antigen molecules. Such a  state would be obtained at very high or very low 
antigen concentrations as has been described for the induction of the tolerant 
state (25). 
SUMMARY 
The in vitro secondary stimulation of the production of anti-hapten antibody 
has been analyzed with a  view to elucidating the role of the carrier molecule 
and  cell-to-cell interactions in this  response.  Stimulation was  carried  out  on 
fragment  cultures  of the  spleens of irradiated BALB/c mice which had been 
reconstituted with 3-4 X  l0  T spleen cells from isologous mice previously im- 
munized with DNP-Hy. The results indicated that the response was maximized 
by stimulation with DNP-Hy,  the homologous complex, however anti-DNP 
antibody production could be obtained by stimulation with DNP  on several 
nonhomologous carriers  including  poly-B-lysine, a poor immunogen. The re- 
sults  also  indicated  that  while  DNP-Hy  and  DNP-nonhomologous-carrier 
complexes  were  stimulatory  at  equally  low  DNP  concentrations,  at  DNP 
concentrations over 10  -6 M DNP-Hy was  stimulatory,  while  DNP  on  non- NORMAN  R.  KLINMAN  971 
homologous carriers was inhibitory.  The results are interpreted  as indicating 
that:  (a) the affinity of the antigen-cell interaction is more likely determined 
by multivalent binding than by carrier recognition, (b) that a stimulatory inter- 
action  of a  polyvalent antigen with a  B-lymphocyte cannot be excluded, (c) 
that if cell-to-cell interaction is necessary for stimulation,  then both cells may 
recognize the same determinant, and (d) that the marked enhancement of anti- 
genie stimulation attributable to carrier recognition may result from stimulatory 
interactions of cells recognizing different antigenic determinants. A mechanism 
is  postulated  whereby  stimulation  is  dependent  on  the  formation  of  stable 
complexes resulting from two cells sharing in the binding of numerous antigen 
molecules. Cells recognizing carrier determinants would increase the probability 
of such interactions particularly at high antigen concentrations. 
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